KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Equity (2016 - 2025)

Historic Return on Equity for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 0.27%.

  • Abbott Laboratories' Return on Equity rose 1300.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.31% for FY2024, which is 1500.0% up from last year.
  • As of Q3 2025, Abbott Laboratories' Return on Equity stood at 0.27%, which was up 1300.0% from 0.28% recorded in Q2 2025.
  • Abbott Laboratories' 5-year Return on Equity high stood at 0.3% for Q4 2024, and its period low was 0.06% during Q1 2021.
  • In the last 5 years, Abbott Laboratories' Return on Equity had a median value of 0.16% in 2023 and averaged 0.19%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 2100bps in 2021, then plummeted by -1000bps in 2023.
  • Over the past 5 years, Abbott Laboratories' Return on Equity (Quarter) stood at 0.21% in 2021, then dropped by -9bps to 0.19% in 2022, then fell by -23bps to 0.15% in 2023, then soared by 104bps to 0.3% in 2024, then decreased by -10bps to 0.27% in 2025.
  • Its Return on Equity was 0.27% in Q3 2025, compared to 0.28% in Q2 2025 and 0.28% in Q1 2025.